生命科学资讯

HIV remission after heterozygous CCR5Δ32 stem cell transplant

Chinese researchers patent new URAT1 inhibitors

Abbisko Therapeutics divulges new SMARCA2 inhibitors

Chengdu Chipscreen Pharmaceutical describes new WRN inhibitors

New CDK inhibitors disclosed in Adlai Nortye patent

Alebund Pharmaceuticals discovers new complement factor B inhibitors

Appointments and advancements for Dec. 1, 2025

Financings for Dec. 1, 2025

In the clinic for Dec. 1, 2025

Other news to note for Dec. 1, 2025

Regulatory actions for Dec. 1, 2025

Med-tech gainers and losers for Nov. 24-26, 2025

Holiday notice

Kymera Therapeutics patents new STAT6 inhibitors

Eli Lilly divulges new RXFP1 agonists

US scientists describe new c-Raf inhibitors

New EGFR inhibitors disclosed in Schrodinger patent

Boehringer Ingelheim discovers new cGAS inhibitors

Blueprint Medicines patents new CDK4 degradation inducers

Gluetacs Therapeutics divulges new protein degradation inducers